Lincoln Capital’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $526K | Sell |
5,737
-1,759
| -23% | -$154K | 0.09% | 91 |
|
|
2026
Q1 | $639K | Sell |
7,496
-490
| -6% | -$43.7K | 0.12% | 79 |
|
|
2025
Q4 | $631K | Sell |
7,986
-202
| -2% | -$15.8K | 0.11% | 84 |
|
|
2025
Q3 | $639K | Sell |
8,188
-1,349
| -14% | -$115K | 0.12% | 84 |
|
|
2025
Q2 | $867K | Sell |
9,537
-89
| -0.9% | -$8.13K | 0.17% | 66 |
|
|
2025
Q1 | $922K | Sell |
9,626
-61
| -0.6% | -$5.46K | 0.19% | 62 |
|
|
2024
Q4 | $881K | Hold |
9,687
| – | – | 0.19% | 58 |
|
|
2024
Q3 | $1.01M | Hold |
9,687
| – | – | 0.21% | 55 |
|
|
2024
Q2 | $940K | Sell |
9,687
-390
| -4% | -$36K | 0.21% | 55 |
|
|
2024
Q1 | $907K | Hold |
10,077
| – | – | 0.2% | 57 |
|
|
2023
Q4 | $803K | Hold |
10,077
| – | – | 0.2% | 57 |
|
|
2023
Q3 | $717K | Buy |
10,077
+100
| +1% | +$7.48K | 0.19% | 57 |
|
|
2023
Q2 | $769K | Hold |
9,977
| – | – | 0.2% | 57 |
|
|
2023
Q1 | $750K | Sell |
9,977
-102
| -1% | -$7.58K | 0.21% | 60 |
|
|
2022
Q4 | $794K | Hold |
10,079
| – | – | 0.23% | 59 |
|
|
2022
Q3 | $708K | Hold |
10,079
| – | – | 0.22% | 58 |
|
|
2022
Q2 | $808K | Hold |
10,079
| – | – | 0.23% | 54 |
|
|
2022
Q1 | $764K | Hold |
10,079
| – | – | 0.18% | 61 |
|
|
2021
Q4 | $860K | Sell |
10,079
-650
| -6% | -$50.8K | 0.21% | 52 |
|
|
2021
Q3 | $811K | Sell |
10,729
-165
| -2% | -$13.1K | 0.22% | 51 |
|
|
2021
Q2 | $886K | Hold |
10,894
| – | – | 0.25% | 47 |
|
|
2021
Q1 | $859K | Hold |
10,894
| – | – | 0.27% | 44 |
|
|
2020
Q4 | $932K | Hold |
10,894
| – | – | 0.3% | 40 |
|
|
2020
Q3 | $840K | Sell |
10,894
-90
| -0.8% | -$6.86K | 0.31% | 42 |
|
|
2020
Q2 | $805K | Hold |
10,984
| – | – | 0.34% | 44 |
|
|
2020
Q1 | $729K | Hold |
10,984
| – | – | 0.37% | 44 |
|
|
2019
Q4 | $756K | Hold |
10,984
| – | – | 0.31% | 40 |
|
|
2019
Q3 | $807K | Hold |
10,984
| – | – | 0.36% | 38 |
|
|
2019
Q2 | $787K | Sell |
10,984
-80
| -0.7% | -$5.68K | 0.35% | 34 |
|
|
2019
Q1 | $758K | Sell |
11,064
-46
| -0.4% | -$2.97K | 0.37% | 35 |
|
|
2018
Q4 | $661K | Buy |
11,110
+76
| +0.7% | +$4.75K | 0.36% | 33 |
|
|
2018
Q3 | $739K | Hold |
11,034
| – | – | 0.37% | 34 |
|
|
2018
Q2 | $717K | Sell |
11,034
-100
| -0.9% | -$6.54K | 0.38% | 33 |
|
|
2018
Q1 | $798K | Sell |
11,134
-436
| -4% | -$31.4K | 0.43% | 34 |
|
|
2017
Q4 | $873K | Hold |
11,570
| – | – | 0.49% | 34 |
|
|
2017
Q3 | $843K | Sell |
11,570
-300
| -3% | -$21.6K | 0.52% | 34 |
|
|
2017
Q2 | $880K | Buy |
11,870
+389
| +3% | +$28.9K | 0.55% | 33 |
|
|
2017
Q1 | $840K | Buy |
11,481
+408
| +4% | +$28.6K | 0.57% | 33 |
|
|
2016
Q4 | $725K | Buy |
11,073
+223
| +2% | +$15.3K | 0.52% | 33 |
|
|
2016
Q3 | $804K | Sell |
10,850
-80
| -0.7% | -$5.91K | 0.59% | 31 |
|
|
2016
Q2 | $800K | Sell |
10,930
-85
| -0.8% | -$6.05K | 0.6% | 31 |
|
|
2016
Q1 | $778K | Buy |
11,015
+440
| +4% | +$29.3K | 0.58% | 33 |
|
|
2015
Q4 | $705K | Hold |
10,575
| – | – | 0.56% | 32 |
|
|
2015
Q3 | $671K | Sell |
10,575
-106
| -1% | -$6.92K | 0.56% | 33 |
|
|
2015
Q2 | $699K | Hold |
10,681
| – | – | 0.59% | 31 |
|
|
2015
Q1 | $741K | Sell |
10,681
-10
| -0.1% | -$691 | 0.64% | 31 |
|
|
2014
Q4 | $740K | Buy |
+10,691
| New | +$722K | 0.64% | 32 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Lincoln Capital's CL Position: Q2 2026 in Review
Lincoln Capital reduced its Colgate-Palmolive (CL) stake by 23% in Q2 2026, selling an estimated $154K and leaving 5,737 shares worth $526K. The position accounts for 0.09% of the portfolio, ranked #91.
Lincoln Capital first reported a position in CL in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.01M in Q3 2024. 621 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Lincoln Capital held 5,737 shares of Colgate-Palmolive worth $526K as of Q2 2026.
- Lincoln Capital sold 1,759 Colgate-Palmolive shares in Q2 2026, an estimated $154K.
- Colgate-Palmolive made up 0.09% of Lincoln Capital's portfolio in Q2 2026, its #91 holding.
- Lincoln Capital first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 47 quarters since.
- Lincoln Capital's Colgate-Palmolive position peaked at $1.01M in Q3 2024.
- 621 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Lincoln Capital's 13F filing for Q2 2026, filed 7 Jul 2026.